A new poll recently published by health policy research firm KFF revealed that roughly 12% of U.S. adults (or one in eight) have taken GLP-1 drugs, a category that includes Wegovy, Ozempic, Zepbound, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results